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Abstract
Analysis of rhesus macaques infected with a vpx deletion mutant virus of simian immunodeficiency virus mac239 (SIVDvpx)
demonstrates that Vpx is essential for efficient monocyte/macrophage infection in vivo but is not necessary for
development of AIDS. To compare myeloid-lineage cell infection in monkeys infected with SIVDvpx compared to
SIVmac239, we analyzed lymphoid and gastrointestinal tissues from SIVDvpx-infected rhesus (n = 5), SIVmac239-infected
rhesus with SIV encephalitis (7 SIV239E), those without encephalitis (4 SIV239noE), and other SIV mutant viruses with low
viral loads (4 SIVDnef, 2 SIVD3). SIV+ macrophages and the percentage of total SIV+ cells that were macrophages in spleen
and lymph nodes were significantly lower in rhesus infected with SIVDvpx (2.2%) compared to those infected with SIV239E
(22.7%), SIV239noE (8.2%), and SIV mutant viruses (10.1%). In colon, SIVDvpx monkeys had fewer SIV+ cells, no SIV+
macrophages, and lower percentage of SIV+ cells that were macrophages than the other 3 groups. Only 2 SIVDvpx monkeys
exhibited detectable virus in the colon. We demonstrate that Vpx is essential for efficient macrophage infection in vivo and
that simian AIDS and death can occur in the absence of detectable macrophage infection.
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Introduction
While all lineages of HIV and SIV encode an accessory protein
termed viral protein R (Vpr), only some, particularly the HIV-2,
SIVSM, and SIVMAC lineages, encode viral protein X (Vpx) [1–3].
Based on sequence similarity to the vpr gene, it has been theorized
that vpx arose as a duplication of an ancestral vpr [3] or as a result
of a recombination event [3,4]. Despite the recognition that Vpx
and Vpr have distinct functions [5], they both have been reported
to play a role in viral replication in macrophages and dendritic
cells [2,6–11]. While Vpr may enhance viral replication in
myeloid-lineage cells in vitro [6], the effect of Vpx on replication
in myeloid cells is even more dramatic [6,7]. Recently it has been
shown that Vpx targets for ubiquitin-mediated proteasomal
degradation a cellular restriction factor, SAM domain HD
domain-containing protein 1 (SAMHD1) [8,9,12–14]. SAMHD1
would otherwise inhibit viral infection of myeloid and dendritic
cells by depleting deoxynucleotide triphosphates (dNTPs) needed
by the lentivirus to complete reverse transcription [9]. SAMHD1
also restricts HIV-1 infection of resting CD4 cells [15,16].
Through mechanisms still under examination, SAMHD1 is also
able to restrict replication of virus transmitted by cell-to-cell
contact to monocyte-derived dendritic cells (MDDCs) [17].
Despite the relatively low infection rate of myeloid and dendritic
cells by HIV-1, examining the role of Vpx in these cells it is
important to understand their role of HIV infection [18].
Although recent studies have elucidated Vpx function in vitro,
there is limited information defining the role and impact of Vpx in
vivo. Two early studies were conducted with Vpx mutant viruses,
one study with mucosal inoculation of pigtail macaques (Macaca
nemestrina) using a SIVSMPBj6.6 vpx-I activated mutant virus [2]
and one in rhesus macaques (Macaca mulatta) infected intravenously
with a vpx deletion mutant of SIVmac239 (SIVDvpx) [19–21]. Viral
replication and dissemination of the vpx-mutant SIVSM during
acute infection were significantly hindered [2]. Likewise, the extent
of SIVDvpx replication was diminished relative to the parental wild
type virus and chronic infection and survival was prolonged
[19–21].
In this study, we analyzed the cellular and tissue targets of viral
replication in adult rhesus monkeys infected with SIVDvpx after
chronic infection at terminal AIDS. The SIVDvpx mutant virus is
identical to SIVmac239 wild-type cloned virus except for the 101
base deletion of the vpx gene from the virus. In previous studies, we
demonstrated that SIVDvpx replicates in rhesus PBMC with only
slightly reduced kinetics, but its replicates in rhesus macrophages
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was markedly impaired with no significant replication noted over
30 days [19].
Cellular and tissue tropism of SIVDvpx-infected macaques were
compared to those of rhesus infected with SIVmac239 with
(SIV239E) or without encephalitis (SIV239noE), SIVDnef, or
SIVD3. SIVD3 is missing nef, vpr, and upstream sequences in U3
[22]. We demonstrate that lack of vpx function results in the near
complete absence of infection in myeloid-lineage cells in vivo even
after several years. Additionally, the colon is particularly devoid of
virus despite the presence of remaining lymphoid cells. Neverthe-
less, all 5 SIVDvpx-inoculated rhesus developed AIDS with
opportunistic infections and AIDS-defining lesions [20]. Taken
together, these findings indicate that Vpx is required for efficient
infection of myeloid-lineage cells in vivo and that the development
of AIDS can occur in the absence of detectable virus replication in
myeloid-lineage cells, including macrophages and dendritic cells.
Results
SIVDvpx-infected rhesus monkeys develop AIDS with
prolonged survival and no encephalitis
The initial infection of five rhesus macaques with SIVDvpx was
described previously by Gibbs et al. [19,20]. Survival of these
SIVDvpx-infected rhesus ranged from 659 to 1241 days post-
inoculation (dpi) with median survival of 1036 dpi (Table 1).
SIVDvpx-infected monkeys had significantly longer survival
(Kruskal-Wallis ANOVA, p= 0.0068) compared to both SIV239E
and SIV239noE monkeys (median survival 438 dpi) (Figure 1a).
All 5 SIVDvpx-infected rhesus developed AIDS with AIDS-
defining lesions including opportunistic infections (Table 2), while
none developed multinucleated giant cell disease (GCD) or SIV
giant cell encephalitis (SIVE), both disease manifestations of
lentiviral infection characterized by histologically distinctive
infected macrophages [23–25].
SIVDvpx plasma viral loads
The original analysis of these SIVDvpx-infected monkeys
revealed lower virus burdens with more PBMCs required to
recover virus in CEMx174 co-cultures compared to SIVmac239
wild-type infected rhesus [20]. To compare plasma viral RNA
levels using current techniques, we used quantitative RT-PCR to
analyze frozen plasma samples from monkeys chronically infected
by SIVDvpx (Figure 1b) and compared the levels to the well-
documented levels in SIVmac239-infected rhesus. Viral RNA
levels in SIVDvpx-infected rhesus from the chronic phase of
infection ranged from 2.96103 to 5.16105 (mean 1.16105,
median 1.76104 RNA copy eq/ml plasma), which are 0.5-2.5
logs lower than usually observed in SIVmac239-infected rhesus
[20,26–28]. SIVDvpx case 4 had the highest near-terminal plasma
viral load (5.16105), but still survived 1068 dpi (almost 3 years)
before succumbing to AIDS. SIVDnef and SIVD3 infected rhesus
had chronic and near-terminal plasma viral loads comparable to
SIVDvpx cases, as previously reported [29].
Viral sequences in SIVDvpx-infected monkeys
The vpx-vpr region was amplified from frozen plasma samples
available from the SIVDvpx-infected rhesus macaques. Alignments
of the predicted amino acid sequences for Vpx, Vpr, and
overlapping Vif and Tat segments were constructed. The original
101 base pair deletion in vpx eliminated Vpx function measured in
vitro and was carefully constructed so as not to affect the
overlapping Vif sequences at its amino terminus or the splice
acceptor for Vpr near the C terminus [19,20]. The deletion was
intentionally made out-of-frame such that vpx sequences down-
stream of the deletion would be out-of-frame with stop codons
immediately flanking the deletion [19,20]. Alignment of sequences
obtained from the plasma samples taken near the time of death
revealed, as expected, consistent preservation of the original 101
bp deletion, which spans the Cullin 4 E3 binding region required
for counteraction of SAMHD1 and efficient myeloid cell infection
in vitro (Figure S1 a, b). Sequences from 2 of the five animals
(cases 4 and 5) revealed additional stop codons in the remaining
vpx sequences (Figure 2), consistent with virus no longer needing
to retain the coding capacity for the vpx sequences that remained
[30]. No consistent patterns of sequence changes were observed in
the portions examined of Vpx, Vpr, Vif or Tat from the five
monkeys (Figure 2). However, Vif sequences in the monkey with
the highest viral loads (#4) did exhibit two novel (not seen in the
Los Alamos Compendium of sequences) amino acid changes
(L-.P and A-.T).
Tissue virus burden and cellular targets
To assess the presence of cellular targets for viral infection in
spleen, lymph node and colon, immunohistochemistry was used to
identify Ham56+ myeloid cells and CD3+ T lymphocytes. The
overall number of Ham56+ myeloid cells (including macrophages
and dendritic cells) did not differ between SIVDvpx-infected
monkeys compared to rhesus infected with SIVmac239 in the
spleen, lymph node, or colon (Figure 3A, B). In addition, there
was no significant difference in the presence of CD3+ T
Table 1. Study cohort of SIVDvpx (n = 5) and SIVmac239
(n = 11) with and without encephalitis.
Inoculum Case # Survival (days) AIDS SIVE
SIVDvpx 1 659 Y N
SIVDvpx 2 673 Y N
SIVDvpx 3 1036 Y N
SIVDvpx 4 1068 Y N
SIVDvpx 5 1241 Y N
mean 935.4/median 1036
SIV239E 6 100 Y Y
SIVmac239 7 103 Y Y
SIVmac239 8 157 Y Y
SIVmac239 9 467 Y Y
SIVmac239 10 535 Y Y
SIVmac239 11 769 Y Y
SIVmac239 12 777 Y Y
SIVmac239 13 103 Y N
SIVmac239 14 173 Y N
SIVmac239 15 392 Y N
SIVmac239 16 431 Y N
mean 364.3/median 438.5
SIVDnef 17 392 Y N
SIVDnef 18 1456 Y N
SIVDnef 19 1642 Y N
SIVDnef 20 2080 Y N
SIVD3 21 1132 Y N
SIVD3 22 1820 Y N
Mean 1420/median 1549
doi:10.1371/journal.pone.0084463.t001
Vpx Essential for Macrophage Infection, Not AIDS
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lymphocytes in the lamina propria of the colon between
SIVmac239 versus SIVDvpx-infected monkeys (Figure 3C).
To analyze the impact of deletion of vpx on tissue virus burden
and tissue tropism, we compared the numbers of SIV+ cells in
available spleen (SPL), peripheral lymph node (LN), and colon
tissues (all when available) among the 4 groups of monkeys.
Photomicrographs of representative sections of in situ labeled SIV+
cells in spleen and lymph node depict high levels of infection in the
SIV239E and SIV239noE monkeys compared to the SIVDvpx
cases (Figure 4A). Total number of infected cells per sections of
SPL and LN showed that there was no significant difference
between the groups (ANOVA, p= 0.0706), but there was a trend
for the highest amount of virus in the SIV239E group (mean 60.15
SIV+ cells), followed by the SIV239noE group (mean 54.75 SIV+
cells), and the SIVDnef/SIVD3 group (mean 42.5 SIV+ cells), with
the least in the SIVDvpx group (mean 23.5 SIV+ cells) (Figure 4B).
Consistent with the plasma viral load data, the combined number
of infected cells in lymphoid tissues (spleen and lymph node)
among the SIVDvpx cases was highest in case #4 (Figure 1b).
The number of SIV infected cells in the colon differed
significantly among the 4 groups (ANOVA, p= 0.0013)
(Figure 5A, B). The mean of SIV+ cells in the colon was
significantly lower in the SIVDvpx-infected monkeys (mean 10.5)
and the SIVDnef/SIVD3 group (mean 6.5) compared to both the
SIV239E (mean 105.3) and the SIV239noE monkeys (mean 33.5)
(p,0.05) (Figure 5B), but did not differ significantly between the
SIVDvpx and SIVDnef/SIVD3 animals. Only 2 of the 5 SIVDvpx
cases (cases 1 and 4) had detectable SIV+ cells in the colon,
whereas 4/5 SIVDnef/SIVD3 infected rhesus had detectable virus
in the colon. In addition, virus was abundant in SIV239E cases
and frequent in SIV239noE cases (Figure 5B). The dearth of SIV
in the colon of SIVDvpx-infected monkeys was not due to a lack of
target lymphocytes and macrophages as both cell types were
abundant at levels not significantly different from SIVmac239-
infected monkeys (Figure 3B, C).
Quantification of SIV infected cell types in vivo
We analyzed the available SPL, LN, and colon tissues from
monkeys in all groups using double-label SIV in situ hybridization
and Ham-56 immunohistochemistry. Images of lymphoid follicles
(top row) depict Ham-56+ cells morphologically consistent with
follicular DCs, while images in the second row depict HAM56+
macrophage/dendritic cells in the red pulp of the spleen (left and
Table 2. SIVDvpx systemic and neuropathologic findings associated with terminal AIDS.
Case # Path # Morphologic Diagnosis
1 A93-673 Wasting with emaciation; bacterial enterocolitis; invasive trichomoniasis
2 A93-695 Adenoviral colitis; SIV arteriopathy; lymphoplasmacytic choroid plexitis
3 A94-594 Adenoviral gastritis; Pneumocystis pneumonia; intestinal trichomoniasis
4 A96-85 Cytomegalovirus, disseminated; Mycobacteriosis, disseminated; Pneumocystis pneumonia; glomerulonephritis;
granulomatous hepatitis
5 A96-368 Pneumocystis pneumonia; intestinal Mycobacteriosis; Cytomegalovirus myelitis, meningitis; severe gastritis
doi:10.1371/journal.pone.0084463.t002
Figure 1. Survival and viral load data. (A) Survival days post-inoculation (dpi) for rhesus macaques inoculated with SIVDvpx compared to
animals inoculated with SIVmac239 (SIV239E with encephalitis or SIV239noE without encephalitis) or other mutant viruses (SIVDnef or SIVD3.
SIVDvpx-infected macaques survived significantly longer with a slower disease progression compared to SIV239E or SIV239noE animals, but did not
differ in survival length compared to SIVDnef or SIVD3. (B) Plasma viral RNA from SIVDvpx-infected rhesus macaques expressed as RNA copy
equivalents per ml plasma from chronic disease or near-terminal collections (range 329–1140 dpi, median 730 dpi).
doi:10.1371/journal.pone.0084463.g001
Vpx Essential for Macrophage Infection, Not AIDS
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center) or paracortex in lymph node (right) (Figure 4 A).
Although the total number of SIV+ cells in SPL and LN did not
differ significantly among the 4 groups, the total number of
infected myeloid-lineage cells, including macrophages and den-
dritic cells, did differ among the groups (ANOVA p=0.0011) with
significantly higher SIV+ macrophage mean in the SIV239E
group (mean 13.6 cells) and SIV239noE (mean 4.5 cells) compared
to SIVDvpx monkeys (mean 0.5 cells) (P,0.05 for both)
(Figure 4C). Of importance is the observation that the number
of SIV+ myeloid cells in the SPL/LN tissues from rhesus in the
SIVDnef/SIVD3 group was significantly higher (p,0.05) than in
the SIVDvpx monkeys while there was no difference in the overall
number of infected cells in these tissues (Figure 4 B, C). SIV
infected macrophages made up a much higher percentage of all
SIV+ cells in SPL and LN of SIV239E (22.7%), SIV239noE
(8.3%), and SIVDnef/SIVD3 monkeys (10.1%) compared to
SIVDvpx (2.2%) (p,0.05) (Figure 4D). This is supported by
additional assays demonstrating that 80.4–100% of SIV+ cells in
the SPL and LN from SIVDvpx monkeys were definitively
identified as CD3+ T cells (Figure 3D). Overall, only 4 infected
macrophages were detected out of 179 SIV+ cells (2.2%) counted
in all SPL and LN sections from the 5 SIVDvpx cases. One animal
(case 4) that had 2 detectable SIV+ macrophages in LN out of 55
SIV+ cells also had the highest plasma viral load (Table 3) and
two novel changes in Vif (L-.P and A-.T) (Figure 2D). Of
interest, is the observation that Ham-56+ myeloid cells with
morphologic features of myeloid dendritic cells in the germinal
centers were also negative for virus. Computer spectral imaging
was used in order to discern spectrally distinct chromagens and to
compare the frequencies of macrophage infection assessed by
counting colabeled (yellow) cells on spectrally unmixed images
(Figure 6).
We performed the same double labeling on colon sections from
the 4 groups of animals (Figure 5A). There was a significant
difference in the total and mean number of infected macrophages
among the 4 groups (ANOVA p=0.0023). The SIV239E (total
467/737, mean 66.7), SIV239noE (30/134, mean 9.8), and
SIVDnef/SIVD3 groups (10/39, mean 3.3) had higher numbers of
SIV+ macrophages in the colon compared to the SIVDvpx group,
in which there were no SIV infected macrophages detected (all
p,0.05) (Figure 5C). This translates into a much lower
percentage of overall SIV+ cells that were macrophages in
SIVDvpx rhesus (0%) compared to SIV239E (63.3%), SIV239noE
(22.4%), and SIVDnef/SIVD3 groups (25.6%) (Figure 5D,
Table 4). As observed in the lymphoid tissues of SPL/LN, the
number of SIV+ macrophages in the colon from rhesus in the
Figure 2. Amino acid sequences from chronic infection plasma viral RNA from SIVDvpx-infected monkeys. (A). Vpx N-terminal
sequences accumulated debilitating mutations in two animals (cases 4 and 5) (*). (B). Novel amino acid sequence changes of Vif were present in case
4 (with highest viral loads) with leucine to proline (L-.P) and alanine to threonine (A-.T). (C). Analysis of Vpr revealed changes in amino acid
sequences detected at the C-terminal region in cases 3 and 4 (I94T, P95L, S99N or G). (D). Alignments of Tat demonstrated multiple non-conservative
changes, such as I22T, S32L, L35P.
doi:10.1371/journal.pone.0084463.g002
Vpx Essential for Macrophage Infection, Not AIDS
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SIVDnef/SIVD3 group was significantly higher than in the
SIVDvpx monkeys while there was no difference in the overall
number of infected cells in these tissues between these 2 groups
(Figure 5 B, C).
The surprising scarcity of SIV-infected cells and complete
absence of SIV+macrophages (0/32 SIV+ cells) in the colon of the
SIVDvpx monkeys highlights a potential role of Vpx and
macrophage tropism in vivo, reflected in a difference in overall
tissue tropism of SIVDvpx with an apparent reduction of virus
trafficking to the colon. The one SIVDvpx-infected monkey (case 1)
with more frequent SIV+ cells in the colon had severe bacterial
enterocolitis, which likely contributed to enhanced immune
activation and immune cell trafficking facilitating viral transport
to the intestinal tract.
Discussion
In this study, we have demonstrated that SIVDvpx is unable to
efficiently infect tissue macrophages in vivo. Although SIVDvpx-
infected animals had prolonged survival, they did eventually
succumb to AIDS with CD4 decline despite the fact that there was
little to no infection of macrophages [20]. Vpx enables infection of
myeloid cells, including macrophage and dendritic cells, with
HIV-2 and SIVmac viruses by inhibiting the recently identified
macrophage restriction factor SAM domain HD domain-contain-
ing protein 1 (SAMHD1) [14]. Vpx loads the SAMHD1 protein
onto the CRL4DCAF1 E3 ubiquitin ligase so that SAMHD1
undergoes proteaosome degradation allowing the virus to replicate
[14]. As a consequence of the deletion of vpx in SIV, only 3 of the 5
SIVDvpx-infected macaques exhibited rare SIV+ macrophages in
lymphoid tissues while the other 2 animals exhibited no
macrophage infection. We also observed that SIVDvpx-infected
animals had little to no virus in the colon despite the fact that there
were target lymphocytes and macrophages present, and there was
a complete absence of detectable SIV+ macrophages in the colon
of any of the SIVDvpx-infected animals. In contrast, macrophage
infection in cloned SIVmac239-infected rhesus occurred at
significantly higher rates, especially in those cases that developed
encephalitis. As an additional comparison group we analyzed
tissues from rhesus infected with SIVDnef or SIVD3. Although
Figure 3. Quantification of tissue macrophages and lymphocytes in SIVDvpx compared to SIVmac239-infected rhesus. (A). Rhesus,
lymph node: representative image of SIV in situ hybridization (ISH, blue) with double-label immunohistochemistry for CD3+ T lymphocytes (DAB,
brown); (B). Quantification of immunophenotyped SIVDvpx-infected cells demonstrates almost exclusive infection of CD3+ T lymphocytes and not
Ham56+ macrophages in spleen and lymph nodes (p,0.05); (C). Numbers of Ham56+ tissue macrophages in the spleen or lymph node and colon
were not significantly different in SIVDvpx-infected rhesus macaques compared to SIVmac239-infected rhesus; (D). Numbers of CD3+ lymphocytes
were not significantly different in the colon in SIVDvpx-infected rhesus macaques compared to SIVmac239-infected rhesus.
doi:10.1371/journal.pone.0084463.g003
Vpx Essential for Macrophage Infection, Not AIDS
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tissue virus burden in SPL/LN and colon from the SIVDnef or
SIVD3 animals were comparable to that of the SIVDvpx-infected
animals, the number of SIV+ tissue macrophages and percentage
of SIV+ cells that were macrophages were significantly lower in
the SIVDvpx group. Nevertheless, all of the SIVDvpx-infected
animals developed AIDS. It has long been postulated that HIV
evolves broader cellular tropism from CD4+ T lymphocytes to
macrophages and that this viral adaptation is necessary for
progression to AIDS [31]. Our findings suggest that macrophage
tropism is not necessary for development of immunosuppression
and AIDS, but may be critical for dissemination of virus to the
intestinal tract.
Figure 4. Double-label immunohistochemistry and in situ hybridization of lymphoid tissues. (A) Representative images of SIV in situ
hybridization (ISH, blue) with double-label immunohistochemistry for monocyte/macrophage lineage cell marker Ham56 (DAB, brown) in rhesus
macaques in groups SIV239E (left), SIV239noE (middle), and SIVDvpx (right). The top images of lymphoid follicles depict Ham-56+ cells
morphologically consistent with follicular DCs. Images in the second row depict HAM56+ cells in the red pulp of the spleen (left and center) or
paracortex in lymph node (right). Frequent SIV+ HAM56+ macrophages/DCs (Mw) were observed in tissues from the SIV239E and SIV239noE groups,
while only rare SIV+ Ham56+ macrophages/DCs were observed in lymph node from a SIVDvpx-infected rhesus (arrow). (B). The overall numbers of
infected cells in the spleen and lymph node from the 4 groups of animals were not significantly different. (C) However, there were significantly fewer
SIV+ Mw in SIVDvpx monkeys (mean 0.5 SIV+ Mw) compared to the SIV239E (mean 13.64 SIV+ Mw), SIV239noE (mean 4.5 SIV+ Mw) and SIVDnef/SIVD3
monkeys (mean 6.25 SIV+ Mw). (D) SIV infected macrophages made up a much lower percentage of all SIV+ cells in SPL and LN of SIVDvpx-infected
rhesus (mean 2.2%) compared to SIV239E (mean 22.7%), SIV239noE (mean 8.3%), and SIVDnef/SIVD3 monkeys (10.1%) (p,0.05).
doi:10.1371/journal.pone.0084463.g004
Vpx Essential for Macrophage Infection, Not AIDS
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The profound and prolonged deficit in the ability of the vpx-
deleted SIV to replicate in macrophages and dendritic cells in
monkeys is consistent with the in vitro data on Vpx function but was
not necessarily an obvious outcome. Wide ranges of culture
conditions have been used for measuring the replication of SIV
and HIV in macrophages in vitro. Both monocyte-derived
macrophages obtained from peripheral blood and bronchoalveolar
macrophages obtained by lung lavage have been used. Stimulating
agents such as granulocyte-macrophage colony stimulating factor
(GM-CSF) and macrophage colony stimulating factor (M-CSF)
are used by some investigators but not others. These stimulants
can have a dramatic effect on the ability of virus to replicate in
macrophage cultures [32–34]. Dramatic differences in the ability
of SIVmac239 and the SIVmac239-derived strain SIVmac316 to
replicate in cultured macrophages are not necessarily reflected in
their ability to replicate in monkeys experimentally infected with
these strains [35]. In addition, SIV has a remarkable ability to
evolve, to adapt, and to optimize its replication. Certainly this is
demonstrated by the evolution of drug-resistant, neutralizing
antibody-resistant, and CTL-resistant strains of SIV and HIV in
Figure 5. Double-label immunohistochemistry and in situ hybridization of colon. (A). Representative images of SIV ISH (blue) with double-
label immunohistochemistry for macrophage marker Ham56 (DAB, brown) in rhesus macaques in groups SIV239E (left), SIV239noE (middle), and
SIVDvpx (right). SIV+ Ham56+ macrophages were frequent in SIV239E monkeys (left), but absent in the SIVDvpx group (right). (B). SIVDvpx-infected
monkeys had significantly less virus in the colon (mean 10.5 SIV+ cells) compared to monkeys infected with SIV239 (SIV239E mean 105.3 SIV+ cells,
SIV239noE mean 33.5 SIV+ cells), but no difference with animals in the SIVDnef/SIVD3 group. (C). SIVDvpx monkeys (mean 0 cells) had significantly
fewer SIV+ Ham56+ macrophages compared to SIV239E (mean 66.7 cells), SIV239noE (mean 9.8 cells), and SIVDnef/SIVD3 groups (mean 3.3 cells)
groups. (D). There was a significantly lower percentage of SIV+ cells that were macrophages in SIVDvpx-infected rhesus (mean 0%) compared to both
the SIV239E (mean 63.3%) and SIV239noE (mean 22.4%) groups and a trend in the SIVDnef/SIVD3 group (mean 25.6%).
doi:10.1371/journal.pone.0084463.g005
Vpx Essential for Macrophage Infection, Not AIDS
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an in vivo setting. Serra-Moreno, et al. have recently demonstrated
that a nef-deleted strain of SIV adapted in monkeys to the loss of
anti-tetherin activity by establishing such activity through muta-
tion of a completely different region of the viral genome, the
cytoplasmic domain of the gp41 transmembrane envelope
glycoprotein [36]. The absence of any reasonable levels of
SIVDvpx replication in macrophages in monkeys, even after two
to three years of ongoing viral replication to provide an
opportunity to adapt, even with the possibility that select pressure
to restore this function may be limited, suggests that it is not easy
for the virus to re-acquire the macrophage-specific vpx functions
lost by its deletion.
Monkeys infected with SIVDvpx had lower viral loads and a
slower progression to AIDS than what is typically observed with
the parental SIVmac239, but nonetheless progressed to simian
AIDS with low CD4 counts and AIDS-defining lesions. Two of the
five SIVDvpx-infected monkeys that died with AIDS had no
detectable infection of macrophages in spleen, lymph node or
colon despite the presence of infected T cells in these animals at
this terminal stage. Analysis of the other three monkeys revealed a
total of four infected macrophages that were found. This dearth of
infected macrophages contrasts markedly with all 11 control
monkeys infected with parental SIVmac239. The frequency with
which SIV encephalitis occurs with SIVmac239 in monkeys (about
30%) and the frequency of infected cells that are macrophages at a
terminal stage appear to be similar to what is seen in HIV-1-
infected people [23,37,38].
What might be the explanation for the few infected macro-
phages that were observed? As with any post-entry restriction
factor, it is likely that there is a significant cell-to-cell variation in
the amounts of SAMHD1 present in any individual macrophage
Figure 6. Spectral imaging and colocalization of double-label immunohistochemistry slides of spleen and colon. Immunofluorescence
with SIV nucleic acid (green), Ham56+ macrophages (red), and coexpression (yellow, arrows) demonstrate that infected macrophages are readily
evident in SIVmac239-infected monkeys (A, B, arrows), particularly within the colon (B), but are absent in spleen and colon from SIVDvpx-infected
monkeys (C, D). Snowflake symbols in C denote autofluorescence in red pulp macrophages. Original magnification 406 (A–D).
doi:10.1371/journal.pone.0084463.g006
Table 3. Phenotype of SIV+ cells in spleen, peripheral lymph
node, and colon of SIVDvpx-infected monkeys by double-label
in situ hybridization and immunohistochemistry.
Case # Tissue HAM56+/SIV+ CD3+/SIV+
1 LN 1/36 25/28
SPL 0/16 19/23
colon 0/27 ND
2 LN 1/49 51/53
SPL ND ND
colon 0/0 ND
3 LN ND ND
SPL 0/4 2/2
colon 0/0 ND
4 LN 2/55 47/56
SPL 0/12 1/1
colon 0/3 ND
5 LN 0/2 0/0
SPL 0/5 7/7
colon ND ND
Total SPL/LN 4/179 (2.2%) 152/170 (89.4%)
Total colon 0/30 ND
TOTAL 4/209 (1.9%) 152/170 (89.4%)
doi:10.1371/journal.pone.0084463.t003
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or in different monocyte-macrophage subtypes. Some rare
macrophages may end up with particularly low levels of SAMHD1
based on stage of differentiation, source, history, and activation
state and these may be weakly susceptible to infection by vpx-
deleted SIV. Alternatively, SAMHD1’s ability to restrict infection
may be down regulated in some cells. As with monkeys infected
with nef-deleted SIV, in which another SIV gene (env) evolved the
capacity for anti-tetherin activity [39], it is also possible that after
many months in vivo the vpx-deleted SIV managed to evolve some
anti-SAMHD1 activity in another SIV gene. In our limited
sequence analysis there were no consistent or highly unusual,
focused changes in the vpr or tat genes at the terminal stages in
these animals to suggest what such change might be, although
there were two novel changes in vif.
Findings in the colon are interesting and potentially informative.
It is now clear that both SIV and HIV-1 cause extremely severe,
sustained depletion of CD4+ CCR5+ T lymphocytes in gut-
associated lymphoid tissue (GALT), including the colon. Severe
depletion of this population of cells has been suggested to drive the
evolution to CXCR4-using HIV-1 late in the course of disease
[40]. It is also conceivable that this depletion of CD4 cells may
drive selection of strains more competent for replication in
macrophages. Breed et al (2013) recently reported that a virus with
a 6 nucleotide deletion from the cytoplasmic tail of SIVmac239
Env (DGY) failed to result in depletion of CD4+CCR5+ cells in
the gut lamina propria and also did not infect macrophages [41]. It
has also been suggested that evolution of highly macrophage-
competent strains of SIV appears late in the course of disease [24]
and monkeys that survive the acute course of a severely CD4-
depleting strain of SHIV exhibit almost exclusive infection of
macrophages in lymphoid tissues many months later [42]. In the
monkeys described here with SIV encephalitis, which had clearly
evolved highly-macrophage-competent SIV, greater than 60% of
the infected cells in the colon on average were macrophages. The
numbers were lower in SIVmac239-infected monkeys that died
without encephalitis, but they are still impressively high. What is
remarkable is the near complete absence of infected macrophages
in colon in the SIVDvpx-infected monkeys. Not only were
macrophages not infected, but also T cells were rarely infected.
In fact, there was a near complete absence of detectable virus in
the colon of the SIVDvpx-infected monkeys. Perhaps infection of
macrophages or dendritic cells is important for promulgating the
infection of the small numbers of CD4+ CCR5+ lymphocytes
remaining in the gut. This supports the recent in vitro findings that
Vpx, by inducing SAMHD1 degradation, is important for HIV-1
transmission between T cells and dendritic cells, which is
important for overall viral dissemination and persistence [17,18].
In summary, we have shown that vpx is required for efficient
myeloid cell infection in experimentally infected rhesus monkeys
and that progression to AIDS and death can occur in the absence
of Vpx and macrophage infection. This is interesting in light of the
recent revelation that Vpx targets SAMHD1 for degradation
[12–14], resulting in increased available dNTPs in macrophages
and dendritic cells as substrates for lentiviral replication [8,9].
Given this demonstrated role of Vpx in SIV-macrophage tropism,
it is reasonable to think that a similar role is played by another
viral protein in HIV-1, which does not encode Vpx. Surprisingly,
HIV-1 Vpr, encoded by vpr, the paralog of vpx, does not inhibit or
antagonize SAMHD1 while other primate Vpr proteins do [43].
From recent phylogenetic studies it is clear that the ability of
primate lentiviruses to degrade SAMHD1 actually predated the
origin of Vpx and was attributed to a neofunctionalization of Vpr
[43]. Evidence of Vpr’s ability to initiate degradation of SAMHD1
exists in several primate lentiviruses, but not in HIV-1 [43]. Since
HIV-1 Vpr does not elicit degradation of human SAMHD1, there
may be another viral protein or a different viral mechanism of
HIV-1 that antagonizes SAMHD1 in order to enable macrophage
and dendritic cell infection.
Materials and Methods
Ethics Statement
All animal studies were performed in accordance with federal
laws and regulations, international accreditation standards, and
institutional policies, including approval by the Institutional
Animal Care and Use Committee of Harvard Medical School.
All animals received two nutritional meals a day and fresh water
ad libitum. All animals received required and approved environ-
mental enrichment and were monitored daily for evidence of
disease and changes in attitude, appetite, or behavior suggestive of
illness. The enrichment program includes weekly rotation of
enrichment devices including a wide variety of manipulanda,
foraging feeders, sensory enrichment, grooming devices, destruc-
tible enrichment, and enrichment food items. Animals are socially
housed except when this interferes with a study. Additional
enrichment is targeted to animals that are assessed as having
abnormal behavior or alopecia. Animals housed in the biocontain-
ment facilities received a daily health check by both animal care
technicians and veterinary professional staff. Appropriate clinical
Table 4. Summaryoflentiviral infection of macrophages in spleen, lymph node, anin macaques inoculated intravenously with
SIVDvpx compared to SIVmac239 (with or without SIV encephalitis) and SIVDnef or D3 assessed in spleen, lymph node, and colon.
Total # of SIV+ cells
that were counted
Total # infected
macrophages
Mean # SIV+
macrophages
% SIV+ cells that were
macrophages
SPL and LN 239E 662 150 13.6 22.7%
SPL and LN 239noE 219 18 4.5 8.22%
SPL and LN Dvpx 179 4 0.5* 2.2%*
SPL and LN Dnef or D3 287 19 4.3 10.1%
Colon 239E 737 467 66.7 63.3%
Colon 239noE 134 30 9.8 22.4%
Colon Dvpx 32 0 0.00025* 0%*
Colon Dnef or D3 39 10 3.3 25.6%
*p,0.05 difference between SIVDvpx and both SIVmac239 and SIVDnef/D3cases.
doi:10.1371/journal.pone.0084463.t004
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support was administered under the direction of the attending
veterinarian and included analgesics, antibiotics, intravenous
fluids, and other supportive care as needed. To ameliorate pain
and suffering, all procedures were performed under ketamine,
Telazol, or an inhalant anesthesia. Analgesics, such as buprenex,
were used preemptively and following each potentially painful
procedure. Animals were humanely euthanized when they
presented with advanced stages of AIDS; criteria for euthanasia
included 15% weight loss in two weeks, unresponsive opportunistic
infection, persistent anorexia, intractable diarrhea, progressive
neurologic signs, significant cardiac or pulmonary signs or other
serious illness. The Harvard Medical School animal management
program is accredited by the Association For Assessment and
Accreditation of Laboratory Animal Care (AAALAC) and meets
National Institutes of Health standards as set forth in ‘‘The Guide
for the Care and Use of Laboratory Animals’’ (National Academy
Press, 1996). The institution also accepts as mandatory the PHS
‘‘Policy on Humane care and use of Laboratory Animals by
Awardee Institutions’’ and the NIH ‘‘Principles for the Utilization
and Care of Vertebrate Animals used in Testing, Research and
Training.’’
Animal cohorts, viral inocula, and clinical summary
The infectious pathogenic SIVmac239 clone [44], the vpx-
deleted derivative of it called SIVDvpx [19], and the nef-deleted
derivative called SIVDnef [45] have been described previously.
SIVD3 is missing nef, vpr, and upstream sequences in U3 [22].
Five adult, Indian origin, rhesus macaques had been inoculated
intravenously with a vpx deletion mutant virus based on parental
cloned SIVmac239 (SIVDvpx) as previously described [19,20].
Complete necropsies with tissue collection had been performed
immediately following euthanasia of all monkeys. Formalin-fixed
paraffin-embedded (FFPE) tissues were sectioned, stained with
hematoxylin and eosin (H&E), and examined for the presence of
macrophage-associated disease including multinucleated giant cell
disease (GCD) and SIV encephalitis (SIVE). In addition, AIDS-
associated lesions and diseases were evaluated and recorded for
SIVDvpx-infected monkeys (Table 2). Archived tissues from adult,
Indian-origin, rhesus macaques inoculated intravenously with
cloned SIVmac239 with AIDS (n= 11), SIVDnef (n = 4), or SIVD3
(n = 2) were also evaluated for comparison (Table 1). The
monkeys with AIDS were selected to represent a spectrum of
disease induced by SIVmac239 and were included based on
survival and progression to AIDS (including rapid and normal
progressors), development of histologic features and opportunistic
infections representative of SIVmac239-infected rhesus, and
severity of encephalitis status, indicative of macrophage involve-
ment. The diagnosis of SIV encephalitis was determined based on
the presence of perivascular collections of SIV-infected macro-
phages and multinucleated giant cells in brain sections. Seven
cases were diagnosed with SIV encephalitis (SIV239E, n= 7) while
the remaining four monkeys lacked encephalitic changes (SIV239-
noE, n = 4).
All animal studies were performed in accordance with federal
laws and regulations, international accreditation standards, and
institutional policies, including approval by the Institutional
Animal Care and Use Committee of Harvard Medical School.
Animals were humanely euthanized when they presented with
advanced stages of AIDS; criteria for euthanasia included 15%
weight loss in two weeks, unresponsive opportunistic infection,
persistent anorexia, intractable diarrhea, progressive neurologic
signs, significant cardiac or pulmonary signs or other serious
illness.
Plasma viral RNA
Plasma viral RNA from SIVDvpx-infected rhesus macaques
were tested by quantitative RT-PCR on stored plasma samples
from chronic disease or near-terminal time points (range 329-1140
dpi, median 730 dpi) using techniques as previously described with
some modifications [46]. Plasma samples harvested from whole
blood collected in heparinized tubes required specialized tech-
niques to purify RNA for real-time RT-PCR analysis. Briefly, viral
RNA was purified using a BioSprint 96 One-For-All Vet Kit
(QIAGEN, Switzerland, Germany, USA) following the manufac-
turer’s recommendations for reagent volumes and elution condi-
tions but processed manually using a Dynal MPCH-96S magnetic
particle concentrator (LifeTechnologies, Grand Island, N.Y.). This
kit purifies RNA by selective binding and release from silica-
paramagnetic particles, eliminating heparin contamination that
would inhibit RT-PCR. The yield recovery of RNA with this
method is comparable to that from the standard method used in
our laboratory [46] (Piatak, et al, unpublished).
Cloning and sequencing of viral genes from SIVDvpx-
infected rhesus plasma
Viral RNA was isolated from the plasma samples collected from
the infected animal using High Pure Viral RNA Kit (Roche),
reverse transcribed with SuperScript III One-Step RT-PCR
System with Platinum Taq High Fidelity (Invitrogen). SIV
sequences were amplified by polymerase chain reaction using
Superscript III kit (Invitrogen) with S-VVout.s (59-AAAAGG-
GTGGCTCAGTACTTATGCAGT-39; positions 5829–5857 in
SIVmac239 sequence) and S-VVout.as (59-GATAAGCAGCT-
GATTCCCAAGACAT-39; positions 6865–6889) for 40 cycles
with primer annealing at 58oC for 300 and primer extension at
68oC for 19200. PCR fragments were cloned directly into pCR2.1
vector using TOPO TA Cloning kit (Invitrogen) and inserts
sequenced on both strands with S-VxVp.s (59-ACTGCATAG-
CACTTATTTCCCTTGCT-39; positions 5919–5944) and S-
VxVp.as (59-ATGCAGAAGATGTATTAGCCTTAGCCTTT-
39; positions 6818–6846) primers at CSHL shared DNA sequenc-
ing resource. The vpx-vpr region was amplified and sequenced
successfully from plasma samples available from the SIVDvpx -
infected rhesus macaques. Viral vpx gene sequences were analyzed
and compared to parental viral clone SIVmac239. Predicted
amino acid sequences for Vpx, Vpr, and overlapping Vif and Tat
segments were constructed, aligned, and compared to parental
viral clone SIVmac239. Alterations in amino acid sequences were
searched against existing NCBI databases to determine novel
mutations.
In situ hybridization
The amount of SIV RNA in tissues was measured in spleen,
peripheral lymph nodes, and colon (all when available) from each
infected macaque in FFPE sections by in situ hybridization because
of its high sensitivity [47]. Tissue sections were rehydrated in
graded ethanol to 1X PBS made with diethyl pyrocarbonate
(Sigma, St. Louis, MO) treated water. Endogenous alkaline
phosphatase activity was blocked with levamisole (Sigma). Tissue
sections were hydrolyzed in HCl (Sigma), digested with proteinase
K (Roche Diagnostics, Indianapolis, IN), acetylated in acetic
anhydride (Sigma), and hybridized overnight at 50uC with a
digoxigenin-labeled antisense riboprobe which spans the entire
genome of the molecular clone SIVmac239 (Lofstrand Labs,
Gaithersburg, MD). Tissue sections were washed extensively and
bound probe was detected using alkaline phosphatase-conjugated
sheep anti-digoxigenin F(ab) fragments (Roche) and the chromogen
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nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate
(NBT/BCIP, Roche). Sections were counterstained with Vector
nuclear fast red (Vector Labs, Burlingame, CA). Sections of brain
from a rhesus macaque with SIV encephalitis served as both positive
control (when incubated with SIV antisense probe) and negative
control (when reacted with SIV sense probe).
Double-label in situ hybridization and
immunohistochemistry of infected cells
Infected cells were characterized by double-label analysis in situ
hybridization for SIVmac and immunohistochemistry with either
anti-CD3 for T lymphocytes or anti-Ham56 for monocyte/
macrophage lineage cells. In situ hybridization was performed as
detailed above followed by routine immunoperoxidase staining on
5-mm formalin-fixed paraffin-embedded sections using standard
avidin-biotin peroxidase complex techniques (Dako, Carpinteria,
CA) as previously described [48,49]. Briefly, sections were
incubated with anti-human CD3 (rabbit polyclonal, Dako) or
anti-human Ham56 antibody (Dako). Sections stained with anti-
CD3 antibody were incubated with biotinylated goat anti-rabbit
secondary antibody (Vector), and sections stained with anti-
Ham56 antibody were incubated with biotinylated horse anti-
mouse secondary antibody (Vector). Tissue sections were washed,
developed with DAB chromogen (Dako), and counterstained with
Vector nuclear fast red. Isotype-matched irrelevant controls were
included for all runs.
Quantification and Spectral Imaging
Sections were evaluated from each animal to derive a mean
number of CD3+ lymphocytes and Ham56+ macrophages and
SIV+ cells per 206 microscopic field as previously described
[50,51]. Briefly, positive cells were counted in 10 non-overlapping
microscopic fields (a minimum of 100 cells or as many cells as
possible). Due to the low number of SIV+ cells in SIVDvpx,
SIVDnef, and SIVD3 cases, the entire slide was examined and all
positive cells were counted for each case. All counting tasks were
performed by two individuals blinded to the original of the slides.
For double-label immunohistochemistry and in situ hybridization,
sections were evaluated to assess percentage of infected cells that
were macrophages per slide using a NuanceTM liquid crystal
tunable filter based camera and multispectral imaging system
(Caliper Life Sciences, Hopkinton, MA) interfaced with a Leica
DMRE microscope. Images of tissue sections were captured
without manipulation and analyzed using Nuance software. When
there were fewer than 100 SIV+ cells the entire section was
screened. Control slides of the following chromogens were used to
make spectral libraries at each relevant magnification: diamino-
benzidine (DAB) for immunohistochemistry, BCIP/NBT (in situ),
and Vector Nuclear Fast Red (counterstain). The spectral
absorbance of each chromogen was established from single stain
controls and the contribution of each stain calculated from this
reference to determine the relative contribution of the stain at each
pixel. Images were automatically acquired from 420 nm to 720 nm
at 20 nm steps and spectral components unmixed. Brightfield
images were unmixed into a composite image and individual
component images for each spectrum analyzed. With different
chromogens unmixed, the numbers of SIV/Ham56 double-
positive macrophages and SIV/CD3 double-positive T-lympho-
cytes were quantified in tissue sections and reported as percent of
infected cells.
Generation of colocalization images was performed by overlay-
ing masks of positive staining cells from the component images. A
standardized threshold of minimum number of pixels determined
each component mask. Simulated fluorescence images were
converted from unmixed brightfield composite images by the
NuanceTM software and then combined into a single image with
colocalized signals represented in yellow.
Statistical analysis
Statistical evaluation and generation of graphs of counted cells
from immunohistochemistry and in situ hybridization assays was
performed with the GraphPad Prism program (La Jolla, CA).
Kruskal-Wallis nonparametric analysis of variance (ANOVA)
followed by Dunn’s multicomparison test were used to assess
statistical differences between groups for each test with statistical
differences assumed for probability values of p,0.05. For
significant ANOVA, nonparametric Mann-Whitney t tests were
performed for comparisons of mean number of infected cells and
percent of SIV+ cells that are macrophages between groups with
statistical differences assumed for p,0.05.
Supporting Information
Figure S1 Complete predicted amino acid sequences
for Vpx (S1a) and Vpr (S1b) derived from viral RNA
sequences from plasma. Cullin 4 E3 binding region, required
for counteraction of SAMHD1, is specified in sequence alignment
of Vpx.
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